Information Dissemination via Wireless Broadcast

The advent of sensor, wireless and portable device technologies will soon enable us to embed computing technologies transparently in the environment to provide uninterrupted services for our daily life. With temperature and location sensors and wireless access points embedded in a

Data Management in Location-Dependent Information Services: Challenges and Issues

this article, we discuss location -dependent information access in a mobile-pervasive environment, in particular in a cellular mobile system, and present new research issues arising from on-demand access, broadcast, and data cachin

Neoadjuvant chemoimmunotherapy cycle number selection for non-small cell lung cancer and clinical outcomes: a real-world analysis

ObjectivesNeoadjuvant chemoimmunotherapy is the optimal choice in the treatment of NSCLC; however, the optimal number of therapeutic cycles remains unclear. The primary aim of this study was to determine the optimal number of neoadjuvant therapeutic cycles in NSCLC.MethodsThis study was a real-world clinical analysis that included patients who received neoadjuvant chemoimmunotherapy followed by surgery from January 2020 to August 2022. Patients were divided into two groups based on the number of therapeutic cycles: 2-cycle group and 3-4-cycles group. The primary endpoint was the major pathological response (MPR) rate.ResultsA total of 251 patients were included: 150 in the 2-cycle group and 101 in the 3-4-cycles group. Baseline characteristics were well-balanced between the groups. The MPR in the 2-cycle group was 57.3% and not significantly different from that of 57.4% in the 3-4-cycles group (p=0.529). Thirty-two patients (31.7%) in the 3-4-cycles group underwent surgery > 42 days after the final cycle of neoadjuvant therapy, significantly more than the 24 patients (16.0%) in the 2-cycle group (p=0.003). The incidence of adverse events related to neoadjuvant therapy was higher in the 3-4-cycles vs 2-cycle groups (72.3% versus 58.0%, respectively; p=0.021), while the 2-cycle group had a higher rate of postoperative morbidities (28.0% versus 12.9%, respectively; p=0.004). Additionally, for patients with ≤ 44.2% regression in diameter on computed tomography after two cycles of treatment, the MPR rate was higher in the 3-4-cycles vs 2-cycle group (47.3% versus 29.9%, respectively; p=0.048). For cases with programmed death-ligand 1 expression, regarding tumor proportion score ≤ 10%, 3-4 cycles of neoadjuvant treatment increased the MPR rate compared with 2 cycles (37.5% versus 9.5%, respectively; p=0.041).ConclusionOur data support the positive role of chemoimmunotherapy in the neoadjuvant treatment of NSCLC. Extending to 3–4 cycles instead of 2 cycles of neoadjuvant chemoimmunotherapy may improve the safety of surgery and result in a lower incidence of postoperative morbidities; however, the MPR rate may not increase significantly. CT re-evaluation during treatment and PD-L1 expression at initial diagnosis are potential indicators to guide the choice of the number of therapeutic cycles

Engineering oxygen vacancies in hierarchically Li-rich layered oxide porous microspheres for high-rate lithium ion battery cathode

Abstract(#br)Lithium-rich layered oxides always suffer from low initial Coulombic efficiency, poor rate capability and rapid voltage fading. Herein, engineering oxygen vacancies in hierarchically Li 1.2 Mn 0.54 Ni 0.13 Co 0.13 O 2 porous microspheres (L@S) is carried out to suppress the formation of irreversible Li 2 O during the initial discharge process and improve the Li + diffusion kinetics and structural stability of the cathode mateiral. As a result, the prepared L@S cathode delivers high initial Coulombic efficiency of 92.3% and large specific capacity of 292.6 mA h g −1 at 0.1 C. More importantly, a large reversible capacity of 222 mA h g −1 with a capacity retention of 95.7% can be obtained after 100 cycles at 10 C. Even cycled at ultrahigh rate of 20 C, the L@S cathode can..

Surface Ni-rich engineering towards highly stable Li 1.2 Mn 0.54 Ni 0.13 Co 0.13 O 2 cathode materials

Abstract(#br)Li-rich layered oxide cathode materials (LLOs) are regarded as promising next-generation cathode candidate in high-energy-density lithium ion batteries due to their high specific capacity over 250 mA h g −1 . However, LLOs always suffer from a series of severe issues, such as rapid voltage fading, fast capacity decay and bad cycling stability. In this work, Li 1.2 Mn 0.54 Ni 0.13 Co 0.13 O 2 -Li 1.2 Mn 0.44 Ni 0.32 Co 0.04 O 2 (LLO-111@111/811) hybrid layered-layered cathode is constructed via facilely increasing surface Ni content. Profiting from this special design, the prepared LLO-111@111/811 cathode exhibits a remarkable specific capacity of 249 mA h g −1 with a high capacity retention of 89.3% and a high discharge voltage of 3.57 V with a voltage retention of 83.0% after cycling 350 times at 0.5 C. As a result, the specific energy of LLO-111@111/811 cathode is 887 Wh Kg −1 at 0.5 C and it keeps as high as 658 Wh Kg −1 after 350 cycles. LLO-111@111/811 also exhibits an initial high capacity of 169 mA h g −1 at a high rate of 5 C and maintains a good capacity retention of 90.0% after 200 cycles. This strategy can successfully improve structural stability, suppress capacity decay and restrain voltage fading of LLOs, which is beneficial for their practical application